In vivo models exhibited a reduction in epithelial markers including E-cadherin and β-catenin, but upon CUR and CIS treatment, their expression was restored, and the N-cadherin (a mesenchymal marker) expression was diminished [49]. Here, CDH1 is linked to in situ carcinoma.